基于“脾气散精”理论探讨肠道菌群与心血管疾病的关系
The Relationship between Gut Microbiota and Cardiovascular Diseases Based on the Theory of “Spleen Qi Dispersing Essence”
摘要: 心血管疾病是全球威胁人类健康的主要疾病之一，近年来随着人类生活水平提高，工作压力与日俱增，致使心血管疾病的发病呈年轻化趋势。心血管疾病具有病程长，易复发，治疗周期长，且难以根治等特点，严重影响患者的生活质量。近年来由于对肠道菌群的不断深入研究，人们逐渐认识到了心血管疾病与肠道菌群之间的相关性。文章基于《黄帝内经》中“脾气散精”理论，结合历代医家的论述及现代研究，探讨“脾气散精”理论、肠道菌群、心血管疾病之间的关系，以丰富中医药治疗心血管疾病的思路。
Abstract: Cardiovascular disease is one of the major diseases that threaten human health globally. In recent years, with the improvement of human standard of living and the increasing pressure of work, the incidence of CVD has shown a trend of rejuvenation. Cardiovascular disease seriously affects the quality of life of patients due to its long duration, easy recurrence, long treatment cycle and difficulty in eradicating the disease. The correlation between cardiovascular disease and gut microbiota has been gradually recognized in recent years due to the increasing research on gut microbiota. Based on the theory of “spleen qi dispersing essence” in Huangdi Neijing, the article combines the discussions of medical experts throughout history and modern research to discuss the relationship between the theory of “spleen qi dispersing essence”, gut microbiota and cardiovascular diseases, in order to enrich the ideas of traditional Chinese medicine in the treatment of cardiovascular diseases.
文章引用：王琪, 杨建飞. 基于“脾气散精”理论探讨肠道菌群与心血管疾病的关系[J]. 临床医学进展, 2024, 14(8): 647-652. https://doi.org/10.12677/acm.2024.1482263

参考文献

[1] 马丽媛, 吴亚哲, 王文, 等. 《中国心血管病报告2017》要点解读[J]. 中国心血管杂志, 2018, 23(1): 3-6.
[2] 中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2020概要[J]. 中国循环杂志, 2021, 36(6): 521-545.
[3] 熊兴江, 王朋倩, 姚魁武, 等. 中医药治疗高血压病研究述评与展望[J]. 中国中药杂志, 2023, 48(24): 6592-6599.
[4] (明)张介宾. 景岳全书[M]. 太原: 山西科学技术出版社, 2006: 205.
[5] 蔡轶, 李玉峰, 肖珉. 健脾益气法调节肠道菌群在心血管疾病中应用探讨[J]. 辽宁中医药大学学报, 2023, 25(7): 110-114.
[6] (唐)王冰. 黄帝内经素问[M]. 北京: 人民卫生出版社, 1963: 112.
[7] 于雪飞, 杨天翼, 康立华, 等. 从“脾藏精”试论糖尿病糖代谢[J]. 环球中医药, 2018, 11(10): 1647-1648.
[8] 许趁意, 岳仁宋, 龙涛, 等. 从“助脾散精”法探讨“胆汁酸-肠道激素”轴对2型糖尿病血糖稳态的影响[J]. 中华中医药杂志, 2022, 37(4): 2231-2234.
[9] Yano, J.M., Yu, K., Donaldson, G.P., Shastri, G.G., Ann, P., Ma, L., et al. (2015) Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis. Cell, 161, 264-276. [Google Scholar] [CrossRef] [PubMed]
[10] 曹宏伟, 姜崴. 胆汁酸诱导的肠道激素与肝脏糖代谢[J]. 中国糖尿病杂志, 2015, 23(12): 1134-1137.
[11] 叶宏, 殷子杰, 熊木红. 从脾虚论治高血压病验案两则[J]. 浙江中医杂志, 2021, 56(6): 459.
[12] 刘佳, 彭颖, 张硕颖, 等. 老年脾虚患者肠道菌群16S rDNA变性梯度凝胶电泳分析[J]. 中华中医药杂志, 2010, 25(10): 1566-1569.
[13] Van Hecke, T., De Vrieze, J., Boon, N., De Vos, W.H., Vossen, E. and De Smet, S. (2018) Combined Consumption of Beef-Based Cooked Mince and Sucrose Stimulates Oxidative Stress, Cardiac Hypertrophy, and Colonic Outgrowth of Desulfovibrionaceae in Rats. Molecular Nutrition & Food Research, 63, Article 1800962. [Google Scholar] [CrossRef] [PubMed]
[14] Yang, T., Santisteban, M.M., Rodriguez, V., Li, E., Ahmari, N., Carvajal, J.M., et al. (2015) Gut Dysbiosis Is Linked to Hypertension. Hypertension, 65, 1331-1340. [Google Scholar] [CrossRef] [PubMed]
[15] Li, J., Yang, X., Zhou, X. and Cai, J. (2021) The Role and Mechanism of Intestinal Flora in Blood Pressure Regulation and Hypertension Development. Antioxidants & Redox Signaling, 34, 811-830. [Google Scholar] [CrossRef] [PubMed]
[16] Li, J., Fu, Y., Qin, S., Liang, G., Liu, J., Nie, X., et al. (2018) Association between P2RY12 Gene Polymorphisms and Adverse Clinical Events in Coronary Artery Disease Patients Treated with Clopidogrel: A Systematic Review and Meta-Analysis. Gene, 657, 69-80. [Google Scholar] [CrossRef] [PubMed]
[17] Wang, B., Qiu, J., Lian, J., Yang, X. and Zhou, J. (2021) Gut Metabolite Trimethylamine-N-Oxide in Atherosclerosis: From Mechanism to Therapy. Frontiers in Cardiovascular Medicine, 8, Article 723886. [Google Scholar] [CrossRef] [PubMed]
[18] 程传浩. 脾胃论白话解[M]. 郑州: 河南科学技术出版社, 2019: 56.
[19] 刘言薇. 基于“心-脾-肠”理论探讨健脾化浊调脂颗粒治疗动脉粥样硬化的机制研究[D]: [博士学位论文]. 南昌: 江西中医药大学, 2019.
[20] Forkosh, E. and Ilan, Y. (2019) The Heart-Gut Axis: New Target for Atherosclerosis and Congestive Heart Failure Therapy. Open Heart, 6, e000993. [Google Scholar] [CrossRef] [PubMed]
[21] Marques, F.Z., Nelson, E., Chu, P., Horlock, D., Fiedler, A., Ziemann, M., et al. (2017) High-Fiber Diet and Acetate Supplementation Change the Gut Microbiota and Prevent the Development of Hypertension and Heart Failure in Hypertensive Mice. Circulation, 135, 964-977. [Google Scholar] [CrossRef] [PubMed]
[22] Pasini, E., Aquilani, R., Testa, C., Baiardi, P., Angioletti, S., Boschi, F., et al. (2016) Pathogenic Gut Flora in Patients with Chronic Heart Failure. JACC: Heart Failure, 4, 220-227. [Google Scholar] [CrossRef] [PubMed]
[23] 胡娟, 汪星辉, 高杉, 等. 肠道菌群在心血管疾病中的作用及其机制研究进展[J]. 中国药理学通报, 2019, 35(11): 1496-1500.
[24] 祝珍珍, 袁灿宇, 袁智宇, 等. 心力衰竭的古病名探究[J]. 中国中医基础医学杂志, 2017, 23(11): 1509-1511.
[25] 庄欣, 李鸿真, 朱明建, 姚晓东. 从脾论治心血管疾病及其与肠道菌群的关系[J]. 中西医结合心脑血管病杂志, 2023, 21(13): 2501-2504.
[26] 叶靖, 吴志阳, 陈文鑫, 等. 刘德桓教授从痰论治高血压病经验[J]. 中医研究, 2015, 28(3): 39-40.
[27] 熊兴江, 王阶. 论半夏白术天麻汤在高血压病中的运用[J]. 中华中医药杂志, 2012, 27(11): 2862-2865.
[28] 韩聪, 姜月华, 李伟, 等. 基于16S rDNA测序技术探索黄芪-丹参药对干预自发性高血压大鼠肠道菌群的机制[J]. 中华中医药杂志, 2019, 34(5): 2233-2237.
[29] Chen, M., Yi, L., Zhang, Y., Zhou, X., Ran, L., Yang, J., et al. (2016) Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota. Molecular Bioinformatics Institutional Cores, 7, e02210-15. [Google Scholar] [CrossRef] [PubMed]
[30] 刘佳, 张立晶, 金晓, 等. 基于“心脾相关”理论辨治冠心病合并抑郁探讨[J]. 环球中医药, 2023, 16(1): 80-82.
[31] 孙思邈. 备急千金要方[M]. 太原: 山西科学技术出版社, 2010: 386.
[32] 张晗, 康立源, 张伯礼. 心脑血管疾病痰瘀互结证述析[J]. 天津中医药, 2009, 26(2): 172-174.
[33] 范永升. 金匿要略[M]. 第2版. 北京: 中国中医药出版社, 2004: 20.
[34] Bae, E., Choo, M., Park, E., Park, S., Shin, H. and Kim, D. (2002) Metabolism of Ginsenoside Rc by Human Intestinal Bacteria and Its Related Antiallergic Activity. Biological and Pharmaceutical Bulletin, 25, 743-747. [Google Scholar] [CrossRef] [PubMed]
[35] 杨钦钦, 陈民利. 中药酚酸类物质通过调节肠道菌群防治心血管疾病的研究进展[J]. 中成药, 2022, 44(12): 3920-3926.
[36] 张丹丹, 叶晓川. 基于肠道菌群和代谢组学探讨茯苓酸性多糖宁心的作用机制[J]. 中华中医药杂志, 2022, 37(5): 2575-2583.
[37] 郑雅玲, 金荣疆, 黄依杰, 等. 基于“脾胃”学说探讨针灸调节肠道菌群的研究概述[J]. 世界科学技术-中医药现代化, 2020, 22(3): 793-798.
[38] 尹克春, 吴焕林. 邓铁涛教授调脾护心法治疗心力衰竭经验[J]. 新中医, 2002, 34(5): 11-12.
[39] 周洪彬, 蔡小丽, 张秋彬, 等. 运脾转枢法在难治性心力衰竭中的运用[J]. 新中医, 2020, 52(10): 172-174.
[40] 訾勇, 罗燕, 蔡晶, 等. 归脾汤对老年慢性心力衰竭心脾两虚型患者心功能和肠道菌群的影响[J]. 广西中医药, 2023, 46(5): 1-5.
[41] Weng, J., Li, J., Yuan, M., Yao, T., Zhang, J., Zeng, Y., et al. (2022) Effects of Buyang Huanwu Decoction on Intestinal Barrier, Intestinal Flora, and Trimethylamine Oxide in Rats with Heart Failure. Chinese Journal of Integrative Medicine, 29, 155-161. [Google Scholar] [CrossRef] [PubMed]
[42] Maalik, A., Bukhari, S.M., Zaidi, A., Shah, K.H. and Khan, F.A. (2016) Chlorogenic Acid: A Pharmacologically Potent Molecule. Acta Poloniae Pharmaceutica, 73, 851-854.
[43] van Duynhoven, J., Vaughan, E.E., van Dorsten, F., Gomez-Roldan, V., de Vos, R., Vervoort, J., et al. (2013) Interactions of Black Tea Polyphenols with Human Gut Microbiota: Implications for Gut and Cardiovascular Health. The American Journal of Clinical Nutrition, 98, 1631S-1641S. [Google Scholar] [CrossRef] [PubMed]

为你推荐